Evidence map›Paper›PMID 41065317›Full record

ArticlePharmaceutical statistics

Designing and Evaluating Bayesian Advanced Adaptive Randomised Clinical Trials: A Practical Guide.

Anders Granholm, Aksel Karl Georg Jensen, Theis Lange, Anders Perner, Morten Hylander Møller, Benjamin Skov Kaas-Hansen

Abstract read
In one paragraph

Article in Pharmaceutical statistics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. INCEPT: The Intensive Care Platform Trial-Design and protocol.Acta anaesthesiologica Scandinavica · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anders GranholmDepartment of Intensive Care 4131, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0001-5799-7655
Aksel Karl Georg JensenDepartment of Intensive Care 4131, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0002-1459-0465
Theis LangeSection of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0001-6807-8347
Anders PernerDepartment of Intensive Care 4131, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0002-4668-0123
Morten Hylander MøllerDepartment of Intensive Care 4131, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0002-6378-9673
Benjamin Skov Kaas-HansenDepartment of Intensive Care 4131, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0003-1023-0371

Funding

Dagmar Marshalls FondDanmarks Frie ForskningsfondGrosserer Jakob Ehrenreich og Hustru Grete Ehrenreichs FondSavværksejer Jeppe Juhl og hustru Ovita Juhls MindelegatSygeforsikringen 'danmark' 2020-0320The Novo Nordisk Foundation NNF23OC0085106
6 · The paper itself

Abstract

Advanced adaptive randomised clinical trials are increasingly used. Compared to their conventional counterparts, their flexibility may make them more efficient, increase the probability of obtaining conclusive results without larger samples than necessary, and increase the probability that individual participants are allocated to more promising interventions. However, limited guidance is available on designing and evaluating the performance of advanced adaptive trials. Here, we summarise the methodological considerations and provide practical guidance on the entire workflow of planning and evaluating advanced adaptive trials using adaptive stopping, adaptive arm dropping, and response-adaptive randomisation within a Bayesian statistical framework. This comprehensive practical guide covers the key methodological decisions for Bayesian advanced adaptive trials and their specification and evaluation using statistical simulation. These considerations include interventions and common control use; outcome type and generation; analysis timing and outcome-data lag; allocation rules; analysis model; adaptation rules for stopping and arm dropping; clinical scenarios assessed; performance metrics; calibration; sensitivity analyses; and reporting. The considerations are covered in the context of realistic examples, along with simulation code using the adaptr R package. In conclusion, this practical guide will help clinical trialists, methodologists, and biostatisticians design and evaluate Bayesian advanced adaptive trials.

Indexed as

Adaptive Clinical Trials as TopicRandomized Controlled Trials as TopicResearch DesignBayes TheoremComputer SimulationHumansModels, Statisticaladaptive trialsBayesian statisticsrandomisationrandomised clinical trialresponse‐adaptive randomisationsimulationtrial design

Identifiers

PMID41065317
PMCPMC12509790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.